Elkayam, Ori

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Meidan, R., et al. (2021) · Annals of the Rheumatic Diseases

SARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and Therapies

Cited by 654

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations

Rondaan, C., Furer, V., Heijstek, M. W., Agmon-Levin, N., Bijl, M., Breedveld, F. C., D’Amelio, R., Dougados, M., Kapetanovic, M. C., van Laar, J. M., et al. (2019) · RMD Open

Rheumatoid Arthritis Research and TherapiesVaccine Coverage and Hesitancy

Cited by 154

A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis

Paran, D., Elkayam, O., Mayo, A., Paran, H., Amit, M., Yaron, M., & Caspi, D. (2001) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 56